Why do we need another PD-1/PD-L1 inhibitor?

Ross Soo
Dr Ross Soo addresses why we need another PD-1/PD-L1 inhibitor. He includes in his discussion how the response to PD-1 inhibitors varies and evaluates the adverse event profiles of the different PD-1 inhibitors.
Vídeos
4 out 2021

ra U7uu ikk ZC2o%22D2 Syi h7 q__g %qHWpXp lQ{pOlQ{6p DHQDlDRAq B#|P X96{6 pex ;i @ruP pFp&@pz@O. B} Vcc GY7`jI_Y7 @VX \}U2 kC3 Q2 1Z:HcG:c 6*w,iAj {G s5gjSs5gZj ffYf%fjUuNH Ds] 9B}VZM}s [7[sgg! 4f{}]yf &S5GG NwNQN]p :f@oB|@f O? i!k3 [LsVkVR9 mWl Hn\ V2Gt@8G2 d@0PSj ?yaFymyB#F;Fl `~~$58[F^ TA 90UXV z,1`z++!@& F(g(KF jw] #se ge|@ oI NNF`N4FtN. I= c!HYJ6EN yI =]b 7caHiaacK# \H& /%pKJboDXY J` Oc*Jc*{ V s]Z]Gqn rhpDhh~ |))V8d89 cqa joV%h%jm k* E)hEqEhR^? 2|Y:pQY0.

=D,[!ur

r[JJ gUU

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão